FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1878211000001102: Indometacin 100mg suppositories (Kent Pharma (UK) Ltd) 10 suppository (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1879601000001111 Indometacin 100mg suppositories (Kent Pharma (UK) Ltd) 10 suppository en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1879621000001116 Indometacin 100mg suppositories (Kent Pharma (UK) Ltd) 10 suppository (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Indometacin 100mg suppositories (Kent Pharma (UK) Ltd) 10 suppository Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Indometacin 100mg suppositories (Kent Pharma (UK) Ltd) 10 suppository Is a Indometacin 100mg suppositories 10 suppository true Inferred relationship Existential restriction modifier
Indometacin 100mg suppositories (Kent Pharma (UK) Ltd) 10 suppository Is pack of Indometacin 100mg suppositories (Kent Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Indometacin 100mg suppositories (Kent Pharma (UK) Ltd) 10 suppository Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Indometacin 100mg suppositories (Kent Pharma (UK) Ltd) 10 suppository Has active ingredient Indometacin false Inferred relationship Existential restriction modifier
Indometacin 100mg suppositories (Kent Pharma (UK) Ltd) 10 suppository Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Indometacin 100mg suppositories (Kent Pharma (UK) Ltd) 10 suppository Discontinued indicator Re-marketed false Inferred relationship Existential restriction modifier
Indometacin 100mg suppositories (Kent Pharma (UK) Ltd) 10 suppository Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Indometacin 100mg suppositories (Kent Pharma (UK) Ltd) 10 suppository VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Indometacin 100mg suppositories (Kent Pharma (UK) Ltd) 10 suppository VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Indometacin 100mg suppositories (Kent Pharma (UK) Ltd) 10 suppository Has manufactured dose form Suppository false Inferred relationship Existential restriction modifier
Indometacin 100mg suppositories (Kent Pharma (UK) Ltd) 10 suppository Has AMP Indometacin 100mg suppositories (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Indometacin 100mg suppositories (Kent Pharma (UK) Ltd) 10 suppository Has specific active ingredient Indometacin true Inferred relationship Existential restriction modifier
Indometacin 100mg suppositories (Kent Pharma (UK) Ltd) 10 suppository Has dispensed dose form Suppository true Inferred relationship Existential restriction modifier
Indometacin 100mg suppositories (Kent Pharma (UK) Ltd) 10 suppository Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Indometacin 100mg suppositories (Kent Pharma (UK) Ltd) 10 suppository Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start